Vascular Intervention // Coronary
Resorbable Magnesium Scaffold (RMS)




     Compelling safety data

     Fast Magnesium resorption time

     Better deliverability





Why Magnesium?





Magnesium alloy: Favorable mechanical properties of a robust Magnesium backbone

Robust Magnesium backbone



The mechanical strength of Magnesium is superior to polymers like PLLA.1

Stable recoil

Magmaris has a 38% lower recoil after 1 hour.2

*Absorb, Abbott

Strong radial resistance

No significant diameter change under increasing physiological pressure.3

Rounded edges and smooth surface



The electropolished rounded edges and smooth surface of the Magmaris scaffold generate less resistance during delivery of the scaffold to the lesion.

Compelling safety data





Confidence through evidence

*Target Lesion Failure. Composite of cardiac and unknown death, target vessel myocardial infarction, clinically driven target lesion revascularization and CABG.
** Patient underwent MIDCAB with subsequent DAPT interruption 5 days after the procedure.

Fast resorption time





~95% of Magnesium resorbed at 12 months7

A more deliverable scaffold





More than 70% of physicians who have used Magmaris RMS in clinical practice have rated the device to be better than a polymeric scaffold.9*

Better lesion crossing



Up to 40% lower lesion entry and crossing force.10

Better trackability in tortuous anatomy

42% less peak force.11

Better pushability

73% more force transmitted from hub to tip.12

* Absorb, Abbott
** BioFreedom, Biosensors






Indicated for de novo coronary artery lesions.*

1-3, 10-13. BIOTRONIK data on file; 4. Verheye S. Safety and Performance of the Resorbable Magnesium Scaffold, Magmaris in a Real World Setting - First Cohort Subjects at 12-month Follow-up of the BIOSOLVE-IV Registry. Presented at: TCT; September 25, 2019; San Francisco, USA. NCT02817802; (n = 2,054; 1,075 patients presented); 5. Haude M. Safety and Clinical Performance of the Drug Eluting Absorbable Metal Scaffold in the Treatment of Subjects with de Novo Lesions in Native Coronary Arteries at 36-month Follow-up-BIOSOLVE-II and -III, Presented at: TCT; September 27, 2019; San Francisco, USA; 6. Haude M, Ince H, Abizaid A. Long-term clinical data and multimodality imaging analysis of the BIOSOLVE-II study with the drug-eluting absorbable metal scaffold in the treatment of subjects with de novo lesions in native coronary arteries - BIOSOLVE-II. Presented at: EuroPCR; May 23, 2018; Paris. France; 7. Haude M, Erbel R, Erne P, et al. Safety and performance of the Drug-Eluting Absorbable Metal Scaffold (DREAMS) in patients with de novo coronary lesions: 3-year results of the prospective, multicenter, first-in-man BIOSOLVE-I trial. EuroIntervention. 2016; 12: e160-e166; 8. Joner M, Ruppelt P, Zumstein P, et al. Preclinical Evaluation of Degradation Kinetics and Elemental Mapping of First and Second Generation Bioresorbable Magnesium Scaffolds. EuroIntervention. 2018 Feb 20. pii: EIJ-D-17-00708. doi: 10.4244/EIJ-D-17-00708. [Epub ahead of print]; 9. BIOSOLVE-II case, GER443-012. Courtesy of M. Haude, Lukaskrankenhaus Neuss, Germany 2015.

Magmaris and BIOlute are trademarks or registered trademarks of the BIOTRONIK Group of Companies. Absorb is a trademark or registered trademark of the Abbott Group of Companies. BioFreedom is a trademark or registered trademark of Biosensors Europe.

*Indication as per IFU

Technical Data

Scaffold material Proprietary Magnesium alloy
Markers Two tantalum markers at each end
Active coating BIOlute bioabsorbable Poly-L-Lactide (PLLA) eluting a limus drug
Drug dose 1.4 μg/mm2
Strut thickness/width 150 μm/150 μm
Maximum expandable diameter Nominal Diameter +0.6 mm
Delivery System
Catheter type Rapid exchange
Recommended guide catheter 6F (min. I.D. 0.070")
Crossing profile 1.5 mm
Guide wire diameter 0.014"
Usable catheter length 140 cm
Balloon material Semi-rystalline polymer
Coating (distal shaft) Dual coated
Marker bands Two swaged platinum-iridium markers
Proximal shaft diameter 2.0F
Distal shaft diameter 2.9F
Nominal pressure (NP) 10 atm
Rated burst pressure (RBP) 16 atm

Compliance Chart

Balloon Diameter x Length (mm)
Nominal Pressure atm8 10 10
(NP) ø (mm) 3.00 3.54
Rated Burst Pressure atm8 16 16
(RBP) ø (mm) 3.29 3.82

Ordering Information

3.00 412526 412527 412528
3.50 412529 412530 412531




Coronary Resorbable Magnesium Scaffold